Sign in

CIK 0001829635 · <br>Emerging growth company

Transcode Therapeutics, Inc.

Sign in to watch
Ticker
RNAZ
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
811065054
Phone
857-301-6857
Business address
6 LIBERTY SQUARE, #2382, BOSTON, MA, 02109
  1. 4 Derivatives Options or other derivatives
  2. 4 Derivatives Options or other derivatives
  3. 4 Derivatives Options or other derivatives
  4. 4 Derivatives Options or other derivatives
  5. 4 Derivatives Options or other derivatives
  6. 4 Derivatives Options or other derivatives
  7. 4 Derivatives Options or other derivatives
  8. 4 Open-market buy Chief Executive Officer bought 20,000 shares at $1.15 ($23,000)
  9. 4 Derivatives Options or other derivatives
  10. 4 Derivatives Options or other derivatives
  11. 4 Derivatives Options or other derivatives
  12. 4 Open-market buy Chief Financial Officer bought 12,000 shares at $1.27 ($15,240)
  13. 4 Open-market buy Chief Executive Officer bought 30,000 shares at an average $1.85 ($55,383)
  14. 4 Derivatives Options or other derivatives
  15. 4 Derivatives Options or other derivatives
  16. 4 Derivatives Options or other derivatives
  17. 3 Insider Initial Statement of Ownership
  18. 3 Insider Initial Statement of Ownership
  19. 3 Insider Initial Statement of Ownership
  20. 3 Insider Initial Statement of Ownership

Page 2 of 3 · 43 filings